We are live on
!
Find out more
Nautilus Biotechnolgy
NAUT
NAUT
82 hedge funds and large institutions have $243M invested in Nautilus Biotechnolgy in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
537% more call options, than puts
Call options by funds: $586K | Put options by funds: $92K
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
1% more funds holding
Funds holding: 81 → 82 (+1)
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
4% more capital invested
Capital invested by funds: $235M → $243M (+$8.62M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2.95% less ownership
Funds ownership: 47.97% → 45.03% (-2.9%)
Holders
82
Holders Change
+1
Holders Change %
+1.23%
% of All Funds
1.29%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
17
Increased
21
Reduced
16
Closed
16
Calls
$586K
Puts
$92K
Net Calls
+$494K
Net Calls Change
-$1.22M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.38M |
| 2 |
TM
Tikvah Management
Charlotte,
North Carolina
|
+$1.06M |
| 3 |
Millennium Management
New York
|
+$1.04M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$566K |
| 5 |
HF
HRT Financial
New York
|
+$456K |
